Cannabis Study House - カナビス文献検索、UKCIA　医学

ＵＫＣＩＡ文献リンク一覧

医学

UK Cannabis Internet Activists (UKCIA)
http://www.ukcia.org/research/researchsearch.php?category=Medical

National Commission on Ganja, Jamaica Aug 7, 2001

Prof. Barry Chevannes, Chairman, et al

A Report of the National Commission on Ganja to the Prime Minister of Jamaica

ジャマイカ首相へのガンジャ諮問委員会報告書

American Review of Respiratory Disease, Volume 109, p. 420-428 1974

Tashkin, Shapiro, and Frank

Acute effects of smoked marijuana and oral d-9-thc on specific airway conductance in asthmatic subjects

喘息患者の特殊気道に対するマリファナ喫煙と経口ＴＨＣ投与の急性反応

Nature vol 435 p1108-1112 23/06/05

Hohmann et al.

An endocannabinoid mechanism for stress-induced analgesia

ストレス性無痛覚症におけるエンドカナビノイドの役割

Multiple Sclerosis 10(4):425-33 August 2004

Brady et al.

An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis.

重傷多発性硬化症患者の膀胱機能障害に対するカナビス抽出薬の非盲検予備研究

Inflammation, Vol 12, No. 4 1988

E.A. Formukong, A.T. Evans, and F.J. Evans

Analgesic and anti-inflammatory activity of constituents of Cannabis Sativa L.

カナビス・サティバの鎮痛抗炎効果成分

GW Pharmaceuticals

Anti-Tumor Effects

カナビスの脳腫瘍縮減効果

New England Journal of Medicine Vol. 293(16) 795-797. 1975

Sallan, Stephen E., Norman E. Zinberg, and Emil Frei.

Antiemetic effect of Delta-9-Tetrahydrocannabinol in patients receiving Cancer Chemotherapy

癌化学療法患者におけるＴＨＣの嘔吐抑制効果

Journal of the National Cancer Institute v55 no. 3 September 1975

Munson, Harris, Friedman, Dewey and Carchman

Antineoplastic activity of cannabinoids

カナビスの抗腫瘍性

Oregon Medical Marijuana Act Debilitating Medical Conditions Advisory Panel 27/03/00

Edward Glick

Anxiety with Depression Research Review

カナビスと鬱の不安症の研究レビュー

British Medical Journal 323(7303):13-6 07/07/01

Campbell et al.

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic reserch

カナビノイドは痛みに対する安全で効果的な補助治療法なのか？定性的統合研究

British Medical Association 18/11/97

BMA report calls for change in law and development of new cannabis-based medicines

法改正と新カナビス医薬品の開発、イギリス医師会が呼びかけ

BBC Online Dec 29, 1998

Body's 'cannabis' could hold blood pressure key

血圧維持に体内カナビスが主要な役割を果たしているのか

Reuters Aug 1997

Johnathon S. Choi

Brain chemicals mimic marijuana

マリファナに似た脳内物質

Proceedings of the National Academy of Sciences Vol. 95, pp. 8268–8273 July 1998

Hampson, Grimaldi, Axelrod and Wink

Cannabidiol and D9-tetrahydrocannabinol are neuroprotective antioxidants

カナビジオールとＴＨＣは神経防護作用物質

Cannabidiol: The Wonder Drug of the 21st Century?

カナビジオール、２１世紀の驚異の医薬品？

TRENDS in Molecular Medicine Vol.8 No.2 February 2002

Mechoulam, Panikashvili, Shohami

Cannabinoids and Brain Injury

カナビノイドと脳の研究

Int J Clin Pharm. Res V (4) 243-246 1985

Volfe Z., Dvilansky A., Nathan I.

Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients

片頭痛患者リンパ漿の血小板からの放出されるセロトニンのカナビノイドによる抑制効果

Nature 20 Jan 2000

David Baker, et al.

Cannabinoids control spasticity and tremor in a multiple sclerosis model

多発性硬化症患者における痙縮と震えに対するカナビノイド治療

British Medical Journal 2001;323:1–8 7/7/01

Tramer et al.

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

吐き気と嘔吐を引き起こす化学療法に対するカナビノイド治療、定量的統合研究

Lancet 2003; 362: 1517–26 2003

Zajicek et al.

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study)

多発性硬化症の痙縮等の症状に対するカナビノイド治療

TheScientificWorldJOURNAL (2002) 2, 632-648 2002

Andrew J. Irving, Mark G. Rae, Angela A. Coutts

Cannabinoids on the Brain

脳内のカナビノイド

Nature Reviews 1 Oct 2003

Manuel Guzman

Cannabinoids: Potential Anticancer Agents

カナビノイド、抗癌剤としての可能性

4 March 1999

The House of Lords, Science and Technology Committee

Cannabis - Government Response

カナビス、政府の対応

European Archives of Psychiatry and Clinical Neuroscience 249 :45–49 1999

Dieter Caspari

Cannabis and schizophrenia: results of a follow-up study

カナビスと精神病、追試研究の結果

Brain vol 126 p1252-1270. 2003

Leslie Iversen

Cannabis and the brain

カナビスと脳

Journal of Psychopharmacology 19(1):3-4. January 2005

Nutt, D.

Cannabis antagonists: a new era of social psychopharmacology?

カナビス拮抗薬、社会精神薬理学の新時代

Multidiciplinary Association for Psychedelic Studies

Ethan Russo, M.D,

Cannabis for Migraine Treatment: The Once and Future Prescription?: An Historical and Scientific Review

カナビスによる片頭痛治療、古代からの未来の処方薬？その歴史と科学的再評価

Journal of Cannabis Therapeutics Vol. 2, No. 3/4, p5-35 2002

Ethan Russo

Cannabis treatments in Obstetrics and Gynecology: A historical review

産科と婦人科におけるカナビス治療の歴史

Prostaglandins, Leukotrienes and Essential Fatty Acids 70 189–197 2004

Boram Park, John McPartland and Michelle Glass

Cannabis, cannabinoids and reproduction

カナビス、カナビノイドとその複製物

1996

Ian Williams Goddard

Cannabis: Medical reality versus authoritarian brutality

カナビス、医薬品としての現実と権威筋の冷遇

4 Nov 1998

The House of Lords, Science and Technology Committee<

Cannabis: The Scientific And Medical Evidence

カナビス、科学的・医学的証拠

International Association for Cannabis as Medicine

Clinical Studies and Case Reports

カナビスの臨床研究とケススタディ報告

Federation of American Societies for Experimental Biology Journal 29/10/01

Maurizio Bifulco et al.

Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth

ラス癌腫瘍遺伝子の腫瘍拡大に対するエンドカナビノイド・システムによる制御

International Journal of Drug Policy 1999

Peter Webster

Counterblast to the I.O.M.

アメリカ医薬品研究所の報告への激しい非難

Addictive Behaviors (electronic publication ahead of print) 17/06/05

Denson and Earleywine

Decreased depression in marijuana users

マリファナ・ユーザーに見られるうつ病減少傾向

BMC Medicine 2004, 2:34 15/09/04

Medveczky, Sherwood, Klein, Friedman, and Medveczky

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro

ＴＨＣによるガンマ発癌性ヘルペスの溶解複製の抑制

Annals of Internal Medicine 91: 819-824 December 1979

Chang et al.

Delta-9-Tetrahydrocannibinol as an antiemetic in cancer patients receiving high-dose Methotrexate

メトトレキサート多量処方がん患者に対するＴＨＣの嘔吐抑制

Proceedings of the National Academy of Sciences vol 100, no 25, 14914-14919 9/12/03

Wang, Matsumoto, Guo, Paria, Roberts, Dey

Differential cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation

アナンダミﾄﾞで選別されたカナビノイド・レセプターが移植時の胚盤胞活性を高める

Wo/Men's Alliance for Medical Marijuana 2001

Valerie Leveroni Corral

Differential effects of medical marijuana based on strain and route of administration:A three-year observation

３年間の観察結果によるカナビス品種と投与法の違いによる医療マリファナの効果の相違

Multiple Sclerosis 10(4):434-441 August 2004

Wade et al.

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis?

カナビスの医薬抽出薬は多発性硬化症の全般あるいは特有の症状に効果があるのか？

British Medical Journal 329 (7460): 253 31/07/04

Svendsen, Jensen, Bach

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis?

カナビノイド製剤ドロナビノールは多発性硬化症の中心性疼痛を緩和するか？

Ophthalmology Vol. 87, No. 3, pp. 222-228 March 1980

Merritt, Crawford, Alexander, Anduze and Gelbart

Effect of marihuana on intraocular and blood pressure in glaucoma

緑内障に対するマリファナの眼圧低下効果

Psychological Medicine, 2003, 33, 23-32. 2003

Verdoux et al.

Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study

精神ストレス脆弱性を持った人の日常生活でのカナビスの影響、サンプリング調査の結果

American Review of Respiratory Disease, Vol. 112 1975

Tashkin, Shapiro, Lee and Harper

Effects of Smoked Marijuana in Experimentally Induced Asthma

実験的に起こした喘息に対するマリファナの煙の影響

Pain 112 (2004) 299–306 2004

Berman, Symonds, Birch

Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus

腕神経叢の中心性神経疼痛に対する２種類のカナビス抽出薬の効能

Multiple Sclerosis 10(4):417-24 August 2004

Vaney et al.

Efficacy, safety and tolerability of an...cannabis extract in the treatment of spasticity in...MS

多発性硬化症の痙縮治療におけるカナビス抽出薬の効能・安全性・耐性

Trends in Neurosciences 28(5):272-6 May 2005

Pryce G, Baker D.

Emerging properties of cannabinoid medicines in management of multiple sclerosis.

多発性硬化症の治療におけるカナビノイド医薬品の特徴を明かす

Journal of Clinical Pharmacology, 2002;42:90S-96S 2002

Todd T. Brown, MD, and Adrian S. Dobs, MD, MHS

Endocrine Effects of Marijuana

マリファナの内分泌腺への影響

Merck Manual of Diagnosis and Therapy, 15th edition 1987

Robert Berkow

Excerpt from the Merck Manual

メルク製薬マニュアルからの抜粋

Proceedings of the National Academy of Sciences 96:25, 14228-14233 07/12/99

L. Hanus et al.

HU308 - A specific agonist for CB2, a peripheral cannabinoid receptor

誘導カナビノイドＨＵ３０８、臓器周辺カナビノイド・レセプターＣＢ２に対する特殊作用薬

Cancer Research 61, 5784-5789 01/08/01

Cristina Sanchez et al.

Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 cannabinoid receptor

ＣＢ２カナビノイド・レセプターの選別作用による生体内での神経膠腫の増殖抑制

Journal of Clinical Investigation 111:43-50 2003

M. Llanos Casanova et al.

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

カナビノイド・レセプターの作用による皮膚癌の増殖抑制効果と血管新生

Anaesthesia, 2004, 59, pp440–452 2004

Notcutt, Price, Miller, Newport, Phillips, Simmons and Sansom

Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 'N of 1' studies

慢性疼痛に対するカナビス抽出薬の初期実験

Nature 434, 782 - 786 07/04/05

Steffens et al.

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice

低水準の経口カナビノイド治療によるマウスの粥状動脈硬化症の進行の抑制

High Times July 1995

Jon Gettman

Marijauna and the brain part 2: The tolerance factor

マリファナと脳ｐａｒｔ２、耐性について

High Times March 1995

Jon Gettman

Marijauna and the human brain

マリファナと人間の脳

Scrip World Pharmaceutical News December 1997

Lisa Nainggolan

Marijuana - a missed market opportunity?

マリファナ、見逃された医薬品市場参入機会

US Institute of Medicine (IOM) 1999

Janet E. Joy, Stanley J. Watson, Jr., and John A. Benson, Jr., Editors

Marijuana and medicine: Assessing the science base

マリファナと医薬品、科学的評価

1996

Robert C. Randall and Alice M. O'Leary

Marijuana as medicine - A recent history (1976-1996) with recommendations

医薬品としてのマリファナ、最近の動向(1976-1996)と提言

Journal of the American Medical Association - Vol. 273, No. 23 1875 21/06/95

Lester Grinspoon and James B. Bakalar

Marijuana as medicine: A plea for reconsideration

医薬品としてのマリファナ、再審議の請願

NIDA Research Monograph 44 1984

Braude and Ludford

Marijuana Effects on the Endocrine and Reproductive Systems

マリファナの内分泌腺と生殖器官に対する影響

The Alliance for Cannabis Therapeutics

Medical cannabis fact sheets

医療マリファナ、ファクトシート

Western Journal of Medicine 1998; 168: 540-543 1998

Jane B. Marmor

Medical Marijuana

医療マリファナ

European Monitoring Centre for Drugs and Drugs Addiction (EMCDDA) May 2002

Medicinal cannabis and derivatives

医療マリファナと派生商品

Hypertension 33(1 Pt 2):429-34. January 1999

Jens A. Wagner, Karoly Varga, Zoltan Jarai, George Kunos

Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors

内皮のアナンダミﾄﾞ・レセプターが介在する腸間膜血管の拡張

British Journal of Pharmacology 140:439-440 2003

Manuel Guzman

Neurons on cannabinoids: dead or alive?

神経細胞に対するカナビノイドの働き、殺すのか生かすのか？

International Journal of Drug Policy Vol 12, 5-6, pp 377-383 01/11/01

Lester Grinspoon

On the pharmaceuticalization of marijuana

マリファナの医薬品化

Clinical Rehabilitation 2003; 17: 21–29 2003

Derick T Wade, Philip Robson, Heather House, Petra Makela and Julia Aram

Preliminary study to determine whether whole-plant cannabis extracts improve intractable neurogenic symptoms

頑固な神経症にカナビス抽出混合液が改善をもたらすか？予備研究

1996

Ian Williams Goddard

Proven: Cannabis is safe medicine

証明、カナビスは安全な医薬品

American Journal of Psychiatry September 1942

Samuel Allentuck and Karl Bowman

Psychiatric aspects of marihuana intoxication

マリファナ陶酔の精神病理学的側面

Addictive Behaviors (electronic publication ahead of print) 18/06/05

Ellingstad et al.

Self-change: A pathway to cannabis abuse resolution

自己改革、カナビス乱用を断つ決断へ道のり

Medline 1998

Some cannabis research from 1975 - present

１９７５年から現在までのカナビス研究の一側面

San Jose Mercury News 24/10/97

Study gauges secondhand smoke toll

間接喫煙被害の測定基準に関する研究

Blood, Vol. 100, No. 2, pp. 627-634 15 July 2002

Robert J. McKallip et al

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

ＣＢ２カナビノイド・レセプターに注目した悪性リンパ腫の新療法

British Journal of Pharmacology 140:547-557 2003

Eric J Downer, Marie P Fogarty and Veronica A Campbell

Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation

ＣＢ１レセプターによる末期的キナーゼ活性の抑制とＴＨＣ誘発神経毒性の制御

Multiple Sclerosis 10 (2004) (Suppl), p. S115. September 2004

J. Zajicek

The cannabinoids in MS study – final results from 12 months follow-up

カナビノイドの多発性硬化症研究、１２ヵ月連続調査の最終結果

Proceedings of the National Academy of Sciences 95: 8375-8380 July 1998

De Petrocellis, Melck, Palmisano, Bisogno, Laezza, Bifulco, Di Marzo

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation

乳癌細胞の増殖に対するエンドカナビノイド、アナンダミﾄﾞの抑制機能

The Journal of Clinical Investigation 113 (8): 1202–1209 15/04/04

Massa F, et al

The endogenous cannabinoid system protects against colonic inflammation

腸炎を防御するエンドカナビノイド・システム

Working Paper Series, University of Hawaii at Minoa June 1996

Ben Wesner

The Medical Marijuana Issue Among PWAs: Reports of Therapeutic Use and Attitudes Toward Legal Reform

エイズ支援グループにおける医療マリファナ問題、医療用途の合法化に向けての考え方

Journal of Neuroimmunology 159(1-2):97-105 2005

Sacerdote P, et al

The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production...

マリファナの非活性成分カナビジオールの走化性緩和

The Lancet Neurology Vol 2 p291-298 May 2003

Baker, Pryce, Giovannoni, and Thompson

The therapeutic potential of cannabis

カナビスの医療利用の可能性

Multiple Sclerosis 10(4):339-40. August 2004

Killestein and Polman

The therapeutic value of cannabinoids in MS: real or imaginary?

多発性硬化症に対するカナビノイドの治療価値、本当に効果があるのか想像か？

Journal of Psychoactive Drugs Apr/Jun 1998

Lester Grinspoon, M.D. & James B. Bakalar

The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder

躁鬱病の気分安定剤としてのカナビスの使用

The British Journal of Psychiatry vol. 178 pp. 107-115 February 2001

Philip Robson

Therapeutic aspects of cannabis and cannabinoids

カナビスとカナビノイドの医療的側面

Journal of Psychoactive Drugs 14: 239-241 1982

Tod Mikuriya

Therapeutic Potential and Medical Uses of Marijuana

マリファナの医療可能性と医薬品としての使用

14 March 2001

The House of Lords, Science and Technology Committee

Therapeutic Uses Of Cannabis

カナビスの医療使用

Multiple Sclerosis 2004 10 (suppl 2): 115 2004

C. Vaney, Berner Klinik

Use of cannabinoids in MS: is it evidence based?

多発性硬化症へのカナビノイドの利用、根拠はあるのか？

▲